Page 26 - The clinical aspects and management of chronic migraine Judith Anne Pijpers

24
Chapter 1
References
1. Goadsby PJ, Holland PR, Martins-oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of Migraine – A disorder of sensory processing. Physiol Rev. 2017;97(2):553-622. doi:10.1152/ physrev.00034.2015
2. Ferrari MD, Klever RR, Terwindt GM, Ayata C, van den Maagdenberg AMJM. Migraine pathophysiology: lessons from mouse models and human genetics. Lancet Neurol. 2015;14(1):65- 80. doi:10.1016/S1474-4422(14)70220-0
3. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629-808. doi:10.1177/0333102413485658
4. Rasmussen B, Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia. 1992;12(4):221-228.
5. Russell MB, Olesen J. A nosographic analysis of the migraine aura in a general population. Brain. 1996;119(2):355-361. doi:10.1093/brain/119.2.355
6. Schoonman G, Evers D, Terwindt G, van Dijk J, Ferrari M. The prevalence of premonitory symptoms in migraine: a questionnaire study in 461 patients. Cephalalgia. 2006;26(10):1209-1213.
7. Giffin N, Ruggiero L, Lipton R, et al. Premonitory symptoms in migraine: an electronic diary study. Neurology. 2003;60(6):935-940.
8. Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population- based cohort: The GEM Study. Neurology. 1999;53(3):537-537. doi:10.1212/WNL.53.3.537
9. Abajobir AA, Abate KH, Abbafati C, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211-1259. doi:10.1016/S0140-6736(17)32154-2
10. May A, Schulte LH. Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol. 2016;12(8):455-464. doi:10.1038/nrneurol.2016.93
11. Bigal ME, Serrano D, Reed M, Lipton RB. Chronic migraine in the population. Neurology. 2008;71:559- 566. doi:10.1212/01.wnl.0000323925.29520.e7
12. Lipton RB, Munjal S, Alam A, et al. Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences. Headache J Head Face Pain. 2018;58(9):1408-1426. doi:10.1111/head.13407
13. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5-HT 1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet. 2001;358(9294):1668-1675. doi:10.1016/ S0140-6736(01)06711-3
14. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990;28(2):183-187. doi:10.1002/ana.410280213
15. Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH. An association between migraine and cutaneous allodynia. Ann Neurol. 2000;47(5):614-624. doi:10.1002/1531- 8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N
16. Schulte LH, May A. Of generators , networks and migraine attacks. Curr Opin Neurol. 2017;30(3):241- 245. doi:10.1097/WCO.0000000000000441
17. Louter M, Fernandez-Morales J, de Vries B, et al. Candidate-gene association study searching for genetic factors involved in migraine chronification. Cephalalgia. 2015;35(6):500-507. doi:10.1177/0333102414547141
18. Yarnitsky D. Role of endogenous pain modulation in chronic pain mechanisms and treatment. Pain. 2015;156 Suppl(2):S24-31. doi:10.1097/01.j.pain.0000460343.46847.58
19. Bernstein C, Burstein R. Sensitization of the trigeminovascular pathway: perspective and implications to migraine pathophysiology. J Clin Neurol. 2012;8(2):89-99. doi:10.3988/jcn.2012.8.2.89
20. Burstein R, Jakubowski M, Garcia-Nicas E, et al. Thalamic sensitization transforms localized pain into widespread allodynia. Ann Neurol. 2010;68(1):81-91. doi:10.1002/ana.21994
21. Jensen TS, Finnerup NB. Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms. Lancet Neurol. 2014;13(9):924-935. doi:10.1016/S1474-4422(14)70102-4
22. Jakubowski M, Silberstein S, Ashkenazi A, Burstein R. Can allodynic migraine patients be identified interictally using a questionnaire? Neurology. 2005;65(9):1419-1422. doi:10.1212/01. wnl.0000183358.53939.38